glp-1 and serotonin What is the risk of syndrome in patients taking a combination of (Glucagon-like peptide-1) receptor agonists, SSRIs (Selective Serotonin Reuptake Inhibitors), ADHD (Attention Deficit Hyperactivity Disorder) medications? Frontiers | GLP-1 Suppresses Feeding
Description
doi: 10.1016/j.soard.2018.03.003

If you're experiencing symptoms, the most important step is to contact the healthcare provider who prescribed your medication

Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

ADP gave substantial contribution to drafting the article or revising it critically for important intellectual content and final approval of the version to be published